Uncategorized

Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years

Sensorion announces that the research partnership framework agreement signed in 2019 with the Institut Pasteur granting Sensorion an option for exclusive licenses to develop and market gene therapy drug candidates from collaborative projects to address unmet medical needs in the hearing field has been extended for a period of five years.

Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years Read More »

SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease

SanReno Therapeutics, a clinical-stage company specializing in the discovery, development, and commercialization of innovative therapies for kidney diseases, announces its acquisition by Novartis, a global medicines company.

SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease Read More »

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

SomaLogic, Inc., a leader in proteomics technology, announced that, based on the preliminary vote count provided by its proxy solicitors following the Company’s Special Meeting of Stockholders held earlier today, SomaLogic stockholders voted to approve the transaction with Standard BioTools Inc. .

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting Read More »

Scroll to Top